The power of Partnership

Contact us
If you have a question about funding opportunities, or any aspect of our international work, please get in touch.
Advocating globally for cancer control
In addition to our International Cancer Prevention (ICP) programme, we work to ensure that the prevention and control of cancer (and other non-communicable diseases), is prioritised in regional and global health policy. As one of the largest non-governmental organisations in the world dedicated to beating cancer, we believe we can play a key role in working with partners to develop and advocate for policies that combat cancer in LMICs.
We focus on building alliances and collaborating with organisations that work in cancer control, and across broader global health and international development communities. We are part of the NCD Alliance, who do vital global policy development and influencing work on the full range of non-communicable diseases. We’re also an active member of the Union for International Cancer Control (UICC), who are the leading network for organisations that fight cancer across the world. Our partnerships with these groups help us to engage more effectively in key forums that help shape global health policy. For example, we supported NCDA to develop its advocacy to the World Health Organization on the revised NCD “Best Buys”, as well as ahead of the 2023 UN High Level Meeting on Universal Health Coverage. We are also a founder member of the World Health Organization’s civil society commission, which is a forum to help shape its broader programme of work.
Working with other organisations beyond the cancer control community is essential if we’re to support LMICs in combatting their cancer burden. In the UK, we engage with civil society networks focussed on Global Health, and NCDs, to advocate for the UK government to prioritise these issues (including cancer control) in its development work. These partnerships will be essential in the coming years, as there is a crucial UN High Level Meeting on NCDs taking place in 2025 which will shape the global agenda. We’ll continue to be a leading voice for cancer control globally in the run up to this meeting, and strongly advocate that cancer is treated as a global health policy priority in the years to come.